Recent studies have shown that CD8+ T cells from severe/critical COVID-19 patients exhibit impaired functions and a limited expansion phenotype compared with mild or moderate cases, despite highly expressed proliferation genes [7,8]. The gene discussed is CD8A; the disease is COVID-19.